HPV-RELATED ADENOCARCINOMA
Clinical trials for HPV-RELATED ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Supercharged immune cells take on HPV cancers
Disease control Recruiting nowThis study tests a new immunotherapy for people with advanced HPV-related cancers (cervical, throat, anal, and others). Participants receive specially engineered immune cells designed to attack HPV-infected tumor cells, along with chemotherapy and a drug to boost cell activity. T…
Matched conditions: HPV-RELATED ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
Immune cells take aim at HPV tumors before standard therapy
Disease control Recruiting nowThis study tests whether giving a single dose of specially engineered immune cells (E7 TCR-T cells) before standard treatment (chemoradiation or surgery) can shrink or eliminate tumors in people with advanced HPV-related cancers. About 15 participants will have their own T cells …
Matched conditions: HPV-RELATED ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Christian Hinrichs • Aim: Disease control
Last updated May 14, 2026 12:05 UTC